| Title : Recombinant human lecithin-cholesterol acyltransferase in patients with atherosclerosis: phase 2a primary results and phase 2b design - Bonaca_2022_Eur.Heart.J.Cardiovasc.Pharmacother_8_243 |
| Author(s) : Bonaca MP , George RT , Morrow DA , Bergmark BA , Park JG , Abuhatzira L , Vavere AL , Karathanasis SK , Jin C , She D , Hirshberg B , Hsia J , Sabatine MS |
| Ref : Eur Heart J Cardiovasc Pharmacother , 8 :243 , 2022 |
| Abstract : |
| PubMedSearch : Bonaca_2022_Eur.Heart.J.Cardiovasc.Pharmacother_8_243 |
| PubMedID: 33493256 |
| Title : LEGACY: Phase 2a Trial to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamic Effects of the Anti-EL (Endothelial Lipase) Antibody MEDI5884 in Patients With Stable Coronary Artery Disease - Ruff_2021_Arterioscler.Thromb.Vasc.Biol__ATVBAHA120315757 |
| Author(s) : Ruff CT , Koren MJ , Grimsby J , Rosenbaum AI , Tu X , Karathanasis SK , Falloon J , Hsia J , Guan Y , Conway J , Tsai LF , Hummer BT , Hirshberg B , Kuder J , Murphy SA , George RT , Sabatine MS |
| Ref : Arterioscler Thromb Vasc Biol , :ATVBAHA120315757 , 2021 |
| Abstract : |
| PubMedSearch : Ruff_2021_Arterioscler.Thromb.Vasc.Biol__ATVBAHA120315757 |
| PubMedID: 34706556 |
| Title : Modulation of lipoprotein metabolism by inhibition of sphingomyelin synthesis in ApoE knockout mice - Park_2006_Atherosclerosis_189_264 |
| Author(s) : Park TS , Panek RL , Rekhter MD , Mueller SB , Rosebury WS , Robertson A , Hanselman JC , Kindt E , Homan R , Karathanasis SK |
| Ref : Atherosclerosis , 189 :264 , 2006 |
| Abstract : |
| PubMedSearch : Park_2006_Atherosclerosis_189_264 |
| PubMedID: 16458317 |